Celcuity Inc.
CELC Nasdaq· Services-Medical Laboratories
Last close · Oct 27, 2026
$68.07
KIRA · Stoqly’s AI analyst, in plain words
- Celcuity Inc. lost $177M in fiscal 2025.
- Free cash flow was −$154M in fiscal 2025, — of revenue.
- Celcuity Inc. has $304M more cash than debt.
Market cap
$3.7B
P/E
—
Revenue
—
Net income
−$177M
Free cash flow
−$154M
Operating margin
—
Celcuity Inc. in 30 seconds · fiscal 2025
Does it make a profit?
−$177M
No. It lost money last year.
How healthy are the accounts?
4 / 7
Mixed. It passes 4 of 7 health tests.
How is the share priced?
—
No P/E: it made no profit over the last four quarters.
What Celcuity Inc. does
No business description yet.
- Fiscal year ends
- December 31, 2025
- Latest annual report
- 10-K · Mar 26, 2026
- Legal name
- Celcuity Inc.
- CIK
- 0001603454
Celcuity Inc. · CELC
Results and finances
The last 5 fiscal years. Amounts in USD.
| Fiscal year | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Sales and profit | |||||
| Net income | −$29.6M | −$40.4M | −$63.8M | −$112M | −$177M |
| Diluted EPS | −$2.21 | −$2.64 | −$2.69 | −$2.83 | −$3.79 |
| Cash | |||||
| Cash from operations | −$20.3M | −$36.0M | −$53.8M | −$83.5M | −$153M |
| Capital expenditure | $0.1M | $0.2M | $0.1M | $0.3M | $0.2M |
| Free cash flow | −$20.4M | −$36.2M | −$53.9M | −$83.7M | −$154M |
| Share count change | 30.3% | 15.2% | 53.6% | 66.6% | 18.5% |
| Debt and strength | |||||
| Cash and short-term investments | $84.3M | $169M | $181M | $235M | $441M |
| Debt incl. finance leases | $16.0M | $35.8M | $37.6M | $105M | $138M |
| Shareholders' equity | $68.7M | $134M | $140M | $116M | $101M |
| Current ratio | 34.1x | 25.5x | 13.4x | 7.7x | 10.5x |
| Interest coverage | −22.5x | −18.7x | −12.4x | −11.0x | −10.0x |
| Returns and quality | |||||
| Return on capital | −5,612.9% | −3,314.1% | — | — | — |
| Return on equity | −73.6% | −39.9% | −46.6% | −87.5% | −163.8% |
| Return on tangible equity | −43.1% | −30.2% | −45.6% | −96.7% | −176.1% |
| Piotroski F-score | — | 2 | 2 | 1 | 4 |
| Altman Z'' | 6.2 | 6.3 | 3.8 | −0.1 | 0.6 |
Insiders bought, 12 months
$0.0M
0 insiders
Insiders sold, 12 months
$328M
3 insiders
Of sales under plans
3%
$9.0M
How to read these numbers
- Revenue:
- Total sales reported in the income statement.
- Operating margin:
- Operating income as a share of revenue.
- Net income:
- Profit after all expenses, interest and tax.
- Free cash flow:
- Cash from operations minus capital spending.
- Net debt / EBITDA:
- Years of EBITDA needed to pay off net debt. Below zero means more cash than debt.
- Return on capital:
- After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Celcuity Inc. · CELC
Charts and comparison
Ten years at a glance, and how it stacks up against similar companies.
Revenue
Net income
Margins, % of revenue
Cash vs debt (incl. leases)
Free cash flow
Dividends and buybacks
KIRA
At $68.07 a share, the company is worth $3.7B.
Source: SEC EDGAR XBRL filings (CIK 0001603454). Data updated October 24, 2026. For information only — not investment advice. Check the original filings before relying on any figure.